# Osmind

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/osmind

- Industry: Healthcare Specialists
- Headquarters: San Francisco, US
- Website: www.osmind.org
- Total disclosed funding: $57M
- Latest round: Series B (May 10, 2022)
- Investors on record: 11

## About

Osmind Inc. is a US-based company specializing in comprehensive solutions for psychiatry practices, focusing on electronic health record management and revenue cycle optimization to enhance operational efficiency and patient care.Osmind Inc. was founded in 2020 and is headquartered in San Francisco, US. The company focuses on developing specialized electronic health record solutions for psychiatry practices. The founders, Jimmy Qian and Lucia Huang, have previously engaged in innovative healthcare solutions. In May 2022, Osmind raised USD 40 mn in Series B funding, led by DFJ Growth, to further develop its offerings and expand its workforce, raising the total amount to USD 40 mn with a current valuation of USD 184.938 mn.Osmind provides a comprehensive suite of solutions tailored to the unique needs of psychiatry practices, with an emphasis on electronic health record (EHR) management and revenue cycle optimization. Their flagship product, Osmind 360, integrates a psychiatry-specialized EHR with billing services and prior authorization support, particularly for Spravato and TMS (Transcranial Magnetic Stimulation). This integrated approach enhances practice efficiency, streamlines operations, and improves patient care, allowing clinicians to focus on patient interactions. Osmind’s services are marketed and utilized nationwide, serving independent psychiatry practices aiming to advance mental health treatment.Osmind generates revenue through a subscription-based model, where psychiatry practices partner to access its EHR and related services. Clients typically pay for tiered subscription plans that include comprehensive support for practice operations, billing, and prior authorization processes. This revenue structure is designed to enhance the practices' profitability and optimize their financial performance by improving net collection rates and facilitating revenue cycle management.In May 2022, Osmind raised USD 40 mn in Series B funding to expand its product offerings and increase its workforce. The company plans to utilize this funding for enhancing both its physical and digital platforms. Future product launches are in development to meet the growing demand for psychiatric solutions, and the company aims to expand its reach into new geographic markets to further support innovative mental health treatment options.

## Funding rounds

- Series B, May 10, 2022, $40M — General Catalyst Partners, Tiger Global Management, Susa Ventures, Pear VC, DFJ Growth, Gaingels, Future Ventures
- Series A, Jul 1, 2021, $15M — General Catalyst Partners, Tiger Global Management, AME Cloud Ventures, Future Ventures, Offline Ventures
- Seed, Oct 14, 2020, $2M — General Catalyst Partners, What If Venture, 20|20 Fund

## Investors

- General Catalyst Partners (https://capitalatlas.ai/funds/general-catalyst-partners) — Seed, Series A, Series B
- What If Venture — Seed
- 20|20 Fund — Seed
- Tiger Global Management (https://capitalatlas.ai/funds/tiger-global-management) — Series A, Series B
- AME Cloud Ventures (https://capitalatlas.ai/funds/ame-cloud-ventures) — Series A
- Future Ventures — Series A, Series B
- Offline Ventures (https://capitalatlas.ai/funds/offline-ventures) — Series A
- Susa Ventures (https://capitalatlas.ai/funds/susa-ventures) — Series B
- Pear VC (https://capitalatlas.ai/funds/pear-vc) — Series B
- DFJ Growth (https://capitalatlas.ai/funds/dfj-growth) — Series B
- Gaingels (https://capitalatlas.ai/funds/gaingels) — Series B